Abstract
to identify and synthesize scientific evidence on prevention and management of extravasation of antineoplastic agents in adult patients by nurses. scoping review, according to Joanna Briggs Institute and PRISMA-ScR. Research was conducted in five electronic databases, Cochrane Library and eight catalogs of theses and dissertations. Data collection occurred from April to July 2018, with no time limit. The extracted data were analyzed and synthesized in a narrative way. a total of 3,110 records were retrieved and 18 studies were kept for review. Most publications (66.6%) had a qualitative approach and addressed both aspects, i.e., prevention and management of extravasation of chemotherapy in adult patients. the implementation of protocols based on scientific evidence on prevention and management of extravasation of antineoplastic agents is paramount in order to provide patient safety and support to the nursing staff.
Highlights
OBJECTIVESMalignant neoplasm has become a health problem worldwide due to its epidemiological, social and economic magnitude
The analysis of the publications found revealed that specific work on prevention and conduct by oncology nurse specialists regarding the extravasation of antineoplastic agents in adult patients began in 1998
The present study summarized the main results and recommendations of research on prevention and management of extravasation of antineoplastic agents in adult patients
Summary
Malignant neoplasm has become a health problem worldwide due to its epidemiological, social and economic magnitude. According to data from the World Health Organization (WHO) International Agency for Research on Cancer (IARC), the incidence in the world has grown by 20% in the last decade(1). It is estimated that by 2030, the number of people affected by this comorbidity in the world will be around 21.4 million. Thirteen point two million will die due to the impact of changes in sociodemographic and epidemiological patterns of the world’s population(2). In Brazil, the estimate for the 2018-2019 biennium will be 600,000 new cases of cancer each year(3). The intervention and treatment process for cancer patients is complex, multidisciplinary and mainly depends on their clinical staging, tumor pathological characteristics and predictive and prognostic factors(2-3)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
